Crossref indexed
Current Drug Discovery Technologies
Published by Bentham Science Publishers Ltd..
ISSN 1570-1638
Submit to this journal
01
Aims & scope
Current Drug Discovery Technologies publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.
02
Recently published
Exploration of Bacopa monnieri–derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma
DOI 10.2174/0115701638486071260907064647 Mudra Sikenis, Anjali Saxena, Abhinav Nair, Biswajit Saha, Subhabrata Kar · 2026
AI Frameworks for the Early Detection and Management of Diabetic Retinopathy: A Real-World Application
DOI 10.2174/0115701638445311260825100649 Harshita, Saumya Das, Priyanka Bansal · 2026
Emerging Therapies in Lung Cancer: A Review on Targeted and Immune Based Interventions
DOI 10.2174/0115701638434891260825091103 KC Geervani, Repollu Maddileti, Kalpi Sania Kausar, Mulla Shaikshavali, Teleke Kumar Swamy, Penugonda Shivarani, E Bhargav · 2026
Therapeutic Potential of Alstonia scholaris (L.) R. Br. in Diabetic Wound Management: An Ethnomedicinal Perspective
DOI 10.2174/0115701638468670260817115618 Santwana Palai, Sarita Jena, Biswakanth Kar, Ritun Patra, Pravas Ranjan Sahoo, Satyajita Sadangi, Kautuk Kumar Sardar · 2026
Artificial Intelligence-powered Advances in Phytomedicine: A Systematic Review on Plant-based Drug Discovery Software
DOI 10.2174/0115701638388155251020065128 Himangi Vig, Ankita Wal, Zia Khanam, Aditi Nigam, Virat Kumar Pandey · 2026
QSAR Modeling of 1,3,4-Oxadiazole Derivatives for Predicting Anticancer
Activity Using SO-PLS Analysis
DOI 10.2174/0115701638474547260730115509 Vijayalakshmi M.K., Srinivasan R · 2026
In Silico Multitarget Profiling of Betulinic Acid: ADME/Protox-II Toxicity, Network Pharmacology, and Molecular Docking for Diabetic Osteoporosis
DOI 10.2174/0115701638476828260801050704 Sheenam Sharma, Rishabh Chaudhary, Chirag Sharma, Swarna Dabral, Seema Bansal, Neelam Sharma, Sumeet Gupta · 2026
Pharmacogenetics and Pharmacogenomics as Enabling Technologies for
Precision Drug Development and Personalized Therapy
DOI 10.2174/0115701638494182260723063335 Nikolet Pavlova, Dimitrios Kaloudas, Martina Traykovska, Robert Penchovsky · 2026
Cannabidiol as a Promising Anti-Inflammatory Agent Targeting TYK2: Molecular Docking and Dynamic Simulation Approaches for Therapeutic Applications in Multiple Sclerosis
DOI 10.2174/0115701638440479260724062842 Fatiha Bousselham, Sanae Baghrous, Ikram Ghicha, Youness Kadil, Vigniako Roussaint DOSSOU-YOVO, Imane Rahmoune, Houda Filali · 2026
AI in Pharma R&D: Bridging Breakthroughs and Future Frontiers
DOI 10.2174/0115701638418225260706154736 Dmitry A. Kudlay, Oleg V. Satyshev, Natalia P. Doktorova, Nikolay Yu. Nikolenko, Andrey A. Svistunov · 2026
Honey–Thyme Oxymel as an Adjunctive Therapy for Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Pediatric Case Report
DOI 10.2174/0115701638464886260703043944 Fatemeh Sajedi, Alireza Derakhshan, Ghasem Amini, Seyed Javad Sayedi · 2026
Phytochemical-based Neuroprotection and In-silico Docking-driven
Identification of Active Natural Compounds to Combat Neuropathy
DOI 10.2174/0115701638469363260629064516 Swathi V., Chandru R., Shabna Roupal Morais, Latha S., Sailendra Kumar Mahanta, Sisir Nandi · 2026
Journal metrics
Total DOIs957
Current DOIs199
Backfile DOIs758
Published here0
Publish with us
Five steps, about 15 minutes. You can save and come back at any point.
Submit manuscript